La Sorda, M.; Fossati, M.; Graffeo, R.; Ferraironi, M.; De Rosa, M.C.; Buzzonetti, A.; Righino, B.; Zampetti, N.; Fattorossi, A.; Nucera, E.;
et al. A Modified Basophil Activation Test for the Clinical Management of Immediate Hypersensitivity Reactions to Paclitaxel: A Proof-of-Concept Study. Cancers 2023, 15, 5818.
https://doi.org/10.3390/cancers15245818
AMA Style
La Sorda M, Fossati M, Graffeo R, Ferraironi M, De Rosa MC, Buzzonetti A, Righino B, Zampetti N, Fattorossi A, Nucera E,
et al. A Modified Basophil Activation Test for the Clinical Management of Immediate Hypersensitivity Reactions to Paclitaxel: A Proof-of-Concept Study. Cancers. 2023; 15(24):5818.
https://doi.org/10.3390/cancers15245818
Chicago/Turabian Style
La Sorda, Marilena, Marco Fossati, Rosalia Graffeo, Manuela Ferraironi, Maria Cristina De Rosa, Alexia Buzzonetti, Benedetta Righino, Nicole Zampetti, Andrea Fattorossi, Eleonora Nucera,
and et al. 2023. "A Modified Basophil Activation Test for the Clinical Management of Immediate Hypersensitivity Reactions to Paclitaxel: A Proof-of-Concept Study" Cancers 15, no. 24: 5818.
https://doi.org/10.3390/cancers15245818
APA Style
La Sorda, M., Fossati, M., Graffeo, R., Ferraironi, M., De Rosa, M. C., Buzzonetti, A., Righino, B., Zampetti, N., Fattorossi, A., Nucera, E., Aruanno, A., Ferrandina, G., Apostol, A. I., Buonomo, A., Scambia, G., Sanguinetti, M., & Battaglia, A.
(2023). A Modified Basophil Activation Test for the Clinical Management of Immediate Hypersensitivity Reactions to Paclitaxel: A Proof-of-Concept Study. Cancers, 15(24), 5818.
https://doi.org/10.3390/cancers15245818